All News

Xalkori improves survival in patients with ALK-positive lymphoma.

Goals and milestone recognitions may help children with cancer get through treatment a little easier.

Clinical trial results suggests that pathologic complete response after HER2-positive therapy equates to great survival.

Aromatase inhibitors may help prevent breast cancer.

When it comes to relieving joint pain from aromatase inhibitors, motion is lotion.

Gazyva may become a standard treatment for older, sicker patient with CLL.

Patients with multiple myeloma fare better with continuous Revlimid (lenalidomide).

The Memory and Attention Adaptation Training (MAAT) program was designed to improve the quality of life and function of cancer survivors who are experiencing post-therapy cognitive issues.

Brain cancer researchers and advocates join resources to help tackle this rare and aggressive malignancy.

Patients battling cancer get financial assistance from friends, family, social media and non-profit organizations.